Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | $368.6K | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | $8.3M | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | $180.1K | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | $817.2K | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | OtherD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | AwardD (derivative) | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Award | — | SEC | |
Forty Seven, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Forty Seven, Inc.Listing unverified | Other | — | SEC | |
Forty Seven, Inc.Listing unverified | Other | — | SEC | |
Forty Seven, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Forty Seven, Inc.Listing unverified | Other | — | SEC | |
Forty Seven, Inc.Listing unverified | Other | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | — | SEC | |
PORTOLA PHARMACEUTICALS INCListing unverified | Other | — | SEC | |
Forty Seven, Inc.Listing unverified | Buy | $1.5M | SEC | |
Forty Seven, Inc.Listing unverified | Buy | $4.5M | SEC |